Inhaled Nitric Oxide (INO) In Hypoxic Respiratory Failure

Summary

This Phase 3, Double-blind, Randomized, Placebo controlled, multicenter study is to confirm the efficacy of inhaled nitric oxide for the management of hypoxic respiratory failure associated with pulmonary hypertension in preterm infants. Study subjects will be administered either inhaled nitric oxide or placebo to determine if there is a change in oxygenation.

Timeline

Start

2009-11

Primary completion

2011-10

Completion

2011-10

Drugs

Indications